
Results
165
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
165 companies
AddLife
Market Cap: SEK 20.1b
Provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 165.30
7D
-3.3%
1Y
-10.9%
Idorsia
Market Cap: CHF 1.7b
A biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada.
IDIA
CHF 6.57
7D
-4.6%
1Y
186.9%
Fujian Haixi Pharmaceuticals
Market Cap: HK$16.3b
Engages in research and development, production, and sale of pharmaceutical products in China.
2637
HK$213.80
7D
18.8%
1Y
n/a
Nanobiotix
Market Cap: €1.8b
Operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs.
NANO
€35.18
7D
13.0%
1Y
745.7%
Lakefront Biotherapeutics
Market Cap: €1.7b
A biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe.
LKFT
€26.40
7D
2.7%
1Y
8.2%
Shenzhen Hepalink Pharmaceutical Group
Market Cap: CN¥12.8b
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
002399
CN¥9.35
7D
4.1%
1Y
-21.2%
Mesoblast
Market Cap: AU$2.7b
Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.
MSB
AU$2.04
7D
4.3%
1Y
28.3%
Nanjing King-Friend Biochemical PharmaceuticalLtd
Market Cap: CN¥12.3b
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
603707
CN¥7.39
7D
4.5%
1Y
-33.0%
Alembic Pharmaceuticals
Market Cap: ₹164.3b
An integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally.
APLLTD
₹835.65
7D
6.2%
1Y
-16.6%
ST PharmLtd
Market Cap: ₩2.6t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩128,700.00
7D
-2.6%
1Y
53.8%
Green Thumb Industries
Market Cap: CA$2.4b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$10.15
7D
-4.8%
1Y
35.2%
Faes Farma
Market Cap: €1.4b
Researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally.
FAE
€4.56
7D
-1.2%
1Y
1.8%
Square Pharmaceuticals
Market Cap: ৳198.2b
Manufactures, markets, and distributes pharmaceutical products in Bangladesh and internationally.
SQURPHARMA
৳223.60
7D
-0.6%
1Y
6.9%
Bonesupport Holding
Market Cap: SEK 15.4b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 234.40
7D
12.0%
1Y
-18.2%
Zhejiang CONBA PharmaceuticalLtd
Market Cap: CN¥10.5b
Engages in the research, development, production, and sales of pharmaceuticals and health products in China.
600572
CN¥4.08
7D
4.1%
1Y
-8.5%
Société de Therapeutique Marocaine
Market Cap: د.م14.1b
A pharmaceutical company, engages in the manufacturing of licensed medicines in Morocco.
SOT
د.م368.30
7D
-2.8%
1Y
22.8%
Porton Pharma Solutions
Market Cap: CN¥9.7b
Provides contract development and manufacturing organization (CDMO) solutions for small molecules, tides, biologics, and conjugates from pre-clinical to commercial in China and internationally.
300363
CN¥18.18
7D
11.9%
1Y
4.8%
BioLife Solutions
Market Cap: US$1.4b
Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.
BLFS
US$27.79
7D
-1.8%
1Y
27.4%
CanSino Biologics
Market Cap: HK$10.2b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$23.12
7D
3.8%
1Y
-33.5%
BioGaia
Market Cap: SEK 12.0b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 119.10
7D
0.9%
1Y
12.3%
AcrobiosystemsLtd
Market Cap: CN¥8.3b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions.
301080
CN¥48.80
7D
1.7%
1Y
-1.0%
Luye Pharma Group
Market Cap: HK$8.1b
Develops, produces, markets, and sells pharmaceutical products in the People’s Republic of China, the United States, Europe, and internationally.
2186
HK$1.99
7D
10.6%
1Y
-39.9%
Amoy Diagnostics
Market Cap: CN¥7.0b
Engages in research and development, production, sale, and supporting services of tumor precision medical diagnostic products in China and internationally.
300685
CN¥17.21
7D
2.2%
1Y
-24.6%
Beijing Strong BiotechnologiesInc
Market Cap: CN¥6.9b
Researches, develops, manufactures, and sells in-vitro diagnostics (IVD) products and services in China and internationally.
300406
CN¥11.35
7D
3.8%
1Y
-18.9%
Saudi Pharmaceutical Industries and Medical Appliances
Market Cap: ر.س3.5b
Develops, manufactures, and markets medicinal and pharmaceutical products in the Kingdom of Saudi Arabia, the Middle East, Egypt, Algeria, and Morocco.
2070
ر.س29.40
7D
4.3%
1Y
13.1%
GC Biopharma
Market Cap: ₩1.4t
A biopharmaceutical company, develops and sells pharmaceutical drugs in South Korea and internationally.
A006280
₩124,300.00
7D
3.4%
1Y
-6.5%
Theravance Biopharma
Market Cap: US$872.8m
A biopharmaceutical company, develops and commercializes medicines in the United States.
TBPH
US$17.00
7D
-0.4%
1Y
50.3%
Basilea Pharmaceutica
Market Cap: CHF 665.7m
A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.
BSLN
CHF 53.70
7D
2.5%
1Y
15.4%
Beijing Beilu Pharmaceutical
Market Cap: CN¥4.9b
Engages in the research, development, production, and sale of pharmaceutical products in China.
300016
CN¥7.99
7D
4.2%
1Y
-21.3%
Getein Biotech
Market Cap: CN¥4.2b
Researches, develops, produces, and sells in vitro diagnostic reagents and instruments in China and internationally.
603387
CN¥8.12
7D
7.4%
1Y
0.1%
MiMedx Group
Market Cap: US$588.3m
Develops and distributes placental tissue allografts for various sectors of healthcare.
MDXG
US$4.07
7D
4.1%
1Y
-37.2%
Mesa Laboratories
Market Cap: US$583.1m
Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.
MLAB
US$102.56
7D
3.0%
1Y
10.4%
Handa Pharmaceuticals
Market Cap: NT$17.9b
A specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States.
6620
NT$107.50
7D
13.0%
1Y
31.9%
Tilray Brands
Market Cap: US$551.1m
A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally.
TLRY
US$4.38
7D
-5.0%
1Y
-13.0%
Beximco Pharmaceuticals
Market Cap: ৳66.9b
Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh and internationally.
BXPHARMA
৳150.00
7D
6.2%
1Y
61.5%
Zhejiang Cheng Yi Pharmaceutical
Market Cap: CN¥3.4b
Zhejiang Cheng Yi Pharmaceutical Co., Ltd.
603811
CN¥7.49
7D
-0.4%
1Y
3.0%